Clinical Trial Update: ADA Gene Transfer Into Hematopoietic Stem/Progenitor Cells for the Treatment of ADA-SCID [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of ADA gene transfer into hematopoietic stem/progenitor cells for ADA-SCID has been completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ada-scid
• Immunologic Deficiency Syndromes

Drugs mentioned

• ADA gene transfer into hematopoietic stem/progenitor cells

Snippet

Sponsor: Fondazione Telethon | Conditions: Immunologic Deficiency Syndromes | Phase 2 | Status: COMPLETED | Results posted: 2020-07-31